Stabilization of the alveolar-capillary barrier with ARF6 inhibitor as a treatment for severe influenza
Ended Project Grant Awarded Last action
- Award ID
- R43HL147780
- Recipient
-
Navigen Inc. UEI S8PXYJQM74M6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $268,075
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $268,075 |
Quick answers
Who received award R43HL147780?
R43HL147780 was awarded to Navigen Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 24, 2019.
How much is award R43HL147780 worth?
$268,075 has been obligated on R43HL147780.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award